radolmidine profile

radolmidine: an alpha2-adrenergic agonist; radolmidine is the HCl salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	6433098
CHEMBL ID	2104262
SCHEMBL ID	2641380
MeSH ID	M0396305

Synonym
L001565
3-(1h-imidazol-5-ylmethyl)-2,3-dihydro-1h-inden-5-ol
fadolmidine
radolmidine
3-(imidazol-4-ylmethyl)-5-indanol
fadolmidine [inn]
radolmidine [inn]
wln5fgh1cy ,
unii-wln5fgh1cy
189353-31-9
CHEMBL2104262
fadolmidine [who-dd]
SCHEMBL2641380
3-(1h-imidazol-4-ylmethyl)-indan-5-ol
VTZPAJGVRWKMAG-UHFFFAOYSA-N
3-((1h-imidazol-5-yl)methyl)-2,3-dihydro-1h-inden-5-ol
3-(1h-imidazol-4-ylmethyl)indan-5-ol
Q27292710
SY356232
3-[(5-imidazolyl)methyl]indane-5-ol

Excerpt	Reference	Relevance
"Radolmidine is a novel alpha2-adrenoceptor agonist with a different pharmacokinetic profile compared with the well-researched dexmedetomidine."	( Effects of radolmidine, a novel alpha2 -adrenergic agonist compared with dexmedetomidine in different pain models in the rat. Kalso, E; Kontinen, VK; Xu, M, 2000)	1.42

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	1 (4.55)	18.2507
2000's	15 (68.18)	29.6817
2010's	2 (9.09)	24.3611
2020's	4 (18.18)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (4.55%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	21 (95.45%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
histamine [no description available]	2.1	1	aralkylamino compound; imidazoles	human metabolite; mouse metabolite; neurotransmitter
bupivacaine Bupivacaine: A widely used local anesthetic agent.. 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.. bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.	2.31	1	aromatic amide; piperidinecarboxamide; tertiary amino compound
clonidine Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.. clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.	3.13	5	clonidine; imidazoline
prazosin Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.. prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.	2.1	1	aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
tizanidine tizanidine: RN given refers to parent cpd; structure. tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.	2.01	1	benzothiadiazole; imidazoles	alpha-adrenergic agonist; muscle relaxant
bicuculline Bicuculline: An isoquinoline alkaloid obtained from Dicentra cucullaria and other plants. It is a competitive antagonist for GABA-A receptors.. bicuculline : A benzylisoquinoline alkaloid that is 6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinoline which is substituted at the 5-pro-S position by a (6R)-8-oxo-6,8-dihydrofuro[3,4-e][1,3]benzodioxol-6-yl group. A light-sensitive competitive antagonist of GABAA receptors. It was originally identified in 1932 in plant alkaloid extracts and has been isolated from Dicentra cucullaria, Adlumia fungosa, Fumariaceae, and several Corydalis species.	2.1	1	benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines	agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin
atipamezole [no description available]	2.44	2
sk&f 95282 zolantidine: structure given in first source	2.1	1	piperidines
dexmedetomidine [no description available]	8.51	8	medetomidine	alpha-adrenergic agonist; analgesic; non-narcotic analgesic; sedative
tannins Tannins: Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS). The two main types are HYDROLYZABLE TANNINS and CONDENSED TANNINS. Historically, the term has applied to many compounds and plant extracts able to render skin COLLAGEN impervious to degradation. The word tannin derives from the Celtic word for OAK TREE which was used for leather processing.	3.12	1
piperidines Piperidines: A family of hexahydropyridines.	2.1	1

Condition	Relationship Strength	Studies
Ejaculatio Praecox [description not available]	2.31	1
Premature Ejaculation The emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.	2.31	1
Allodynia [description not available]	3.14	5
Nerve Pain [description not available]	2.49	2
Neuralgia Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.	2.49	2
Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.	2.04	1
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	2.08	1
Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.	2.01	1
Colitis Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.	2.01	1
Ache [description not available]	3.84	4
Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.	8.84	4
Ocular Hypotension Abnormally low intraocular pressure often related to chronic inflammation (uveitis).	2.02	1
Intraocular Pressure The pressure of the fluids in the eye.	2.43	2
Adjuvant Arthritis [description not available]	2.03	1
Peripheral Nerve Diseases [description not available]	2	1
Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.	2	1
Acute Post-operative Pain [description not available]	2	1
Pain, Postoperative Pain during the period after surgery.	2	1
Innate Inflammatory Response [description not available]	2	1
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.	2	1

radolmidine

Description

Cross-References

Synonyms (20)

Research Excerpts

Overview

Research

Studies (22)

Market Indicators

Research Demand Index: 11.49

Study Types

radolmidine

Description

Cross-References

Synonyms (20)

Research Excerpts

Overview

Research

Studies (22)

Market Indicators

Research Demand Index: 11.49

Study Types

Related Drugs (11)

Related Conditions (20)